Review Article - (2012) Volume 0, Issue 0
Development of Proteasome Inhibitors as Therapeutic Drugs
- Samuel Troy Pellom Jr.1,2,3 and Anil Shanker1,4*
- 1Laboratory of Lymphocyte Function, Department of Biochemistry and Cancer Biology, School of Medicine, Meharry Medical College, Nashville, TN 37208, USA
- 2School of Graduate Studies and Research, Meharry Medical College, Nashville, TN 37208, USA
- 3Department of Microbiology and Immunology, School of Medicine, Meharry Medical College, Nashville, TN 37208, USA
- 4Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA
*Corresponding Author:
Anil Shanker, Department of Biochemistry and Cancer Biology, School of Medicine, Meharry Medical College 2005 Harold D West Basic Sciences Bldg 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208, USA, Tel: 1-615 327 6460, Fax: 1-615 327 6442
Email:
